Business Wire

Brightline Initiative Study Identifies Crisis Mode Learnings that Create Stronger Strategy Implementation Capabilities

Del

In partnership with Quartz Insights, Brightline™ Initiative today announces the release of research report “Learning From Crisis Mode – Implications for Better Strategy Implementation”. The report aimed to discern implications of crisis on better strategy implementation, and participants spanned the globe, with the majority holding C-suite positions (52%) and coming from companies with annual global revenues of $1 billion or more (65%). It provides readers with key practices and recommendations to improve strategy implementation capabilities as well as insights for how to leverage crisis experiences and enact change in non-crisis environments.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181128005908/en/

The report shows that a crisis can have a positive and lasting impact on three key areas of strategy implementation: prioritization of initiatives, speed in decision making and execution of process, and team empowerment.

Key findings include the following:

  • Expect a crisis: 68% of respondents agreed with the inevitability of their organizations facing a crisis in the future, and 91% of respondents agreed that when faced with a crisis, they changed the standard operating procedures. In the survey, we refer to this as “Crisis Mode.”
  • Identify lasting implementations: 79% of respondents agreed that modifications to team structures that were introduced as a result of the crisis remained in place, 74% agreed that close working partnerships between cross-functional teams continued, and 71% agreed that a clearer understanding of the organization’s priorities renewed its vision and sense of direction.
  • Prioritize strategic initiatives: Of the 75% of respondents who reported that experiencing Crisis Mode made them stronger in strategy implementation, 91% reported making changes to their prioritization of strategic initiatives. This re-prioritization implies a willingness to quickly assess what is and isn’t working without fear of abandoning a previously established direction.
  • Empower key employees: Organizations that empowered non-leadership-level employees who were closer to the crisis emerged stronger post-crisis than those that didn’t. 75% of these high performing organizations believe crises uncover talented leaders from within the organizational ranks, allowing those leaders to advance. This responsibility distribution allows for faster communication and fewer roadblocks.

Ricardo Vargas, Executive Director, Brightline Initiative, observed that “A crisis can bring out the best in your staff, unearth improvements in processes, and reveal new business opportunities, all of which can -- and should -- influence post-crisis strategy design and implementation.”

“We were delighted to partner with The Brightline Initiative. We share a common obsession on ensuring that breakthrough ideas are realized, and -- together -- engaged hundreds of individuals to produce a report grounded in rigor, and oriented towards empowering organizations to benefit from disruption and transformation.” - Ernesto Henriquez, Director, Insights & Brand Strategy, Quartz

The report is the result of 18 qualitative interviews and 1,258 quantitative interviews with executives from the government, non-profit and the private sector who have experienced a crisis. The full report, Learning From Crisis Mode, can be viewed online at https://www.brightline.org/learning-from-crisis-mode/.

About Brightline Initiative
The Brightline™ Initiative is a coalition led by the Project Management Institute together with leading global organizations dedicated to helping executives bridge the expensive and unproductive gap between strategy design and delivery. Learn more at www.brightline.org.

Brightline Coalition
Project Management Institute – The Boston Consulting Group – Bristol Myers Squibb – Saudi Telecom Company – Lee Hecht Harrison – Agile Alliance – NetEase

Academic and Research Collaboration
MIT Consortium for Engineering Program Excellence – Technical University of Denmark – University of Tokyo Global Teamwork Lab – Blockchain Research Institute

About Quartz Insights
Quartz Insights is a unit of Quartz’s commercial team obsessed with the topics that matter to people in business, dedicated to providing breakthrough insights, intelligence, and competitive advantage to Quartz’s partners. Quartz Insights conducts research and publishes thought leadership to inform and inspire the leaders of the new economy.

Contact information

Brightline Initiative
Edivandro Conforto
Head of Strategy Research
edivandro.conforto@brightline.org
or
Quartz
Ernesto Henriquez
Director, Insights & Brand Strategy
ehenriquez@qz.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference24.5.2019 14:00:00 CESTPressemelding

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today presented in vitro and in vivo data for the company’s lead molecule for the targeted treatment of KCNQ2-neonatal epileptic encephalopathy (KCNQ2-NEE) at the Antiepileptic Drug and Device Trials XV Conference in Miami, Florida. KCNQ2-NEE, a rare infant genetic epilepsy, results from mutations in genes encoding the Kv7.2/Kv7.3 ion channel, leading to frequent seizures and profound developmental delay. The preclinical data were presented by Steven Dworetzky, Ph.D., Knopp’s Chief Scientific Officer, a longtime Kv7 researcher who led the group that first cloned the Kv7.2 and Kv7.3 genes during his former tenure with the Bristol-Myers Squibb Co. Dr. Dworetzky presented results demonstrating the in vitro nanomolar activity of KB-3061 and its significant seizure protection in the maximal electroshock mo

Accelerate Your Business in South Korea Through 2019 K-Startup Grand Challenge24.5.2019 10:20:00 CESTPressemelding

Entrepreneurs from across the globe should set their sights on participating in the 2019 K-Startup Grand Challenge. Supported by the Ministry of SMEs and Startups and National IT Industry Promotion Agency (NIPA) of South Korea, the initiative provides invaluable support and comprehensive resources to early age startups. Applications for the K-Startup Grand Challenge are currently being accepted through June 14, 2019. In order to advance in the program, teams must pass a regional audition. A judging panel of startup ecosystem experts and Korean accelerators will select 40 teams to participate in an enriching 3.5 month-long acceleration program in Korea. The selected teams will have exclusive access to free office space at the Startup Campus in Pangyo Techno Valley, one-on-one mentoring, information sessions, coaching on Korean and Asian business culture and the chance to attend insightful seminars on accounting regulations to tax laws, patents and more. Opportunities for networking with

New Investigational Clinical Data for Ipsen’s Oncology Products in 11 Solid Tumor Types to Be Presented at 2019 ASCO Annual Meeting24.5.2019 05:00:00 CESTPressemelding

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that new data from clinical studies on investigational uses of cancer medicines cabozantinib (Cabometyx®), liposomal irinotecan (Onivyde®), and lanreotide autogel (Somatuline®, marketed as Somatuline Depot® in the United States) will be presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting takes place in Chicago, Illinois, U.S., 31 May–4 June 2019; data featuring Ipsen medicines includes: New data from the Phase 3 CELESTIAL trial on the association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma Overview of the Phase 3 COSMIC-312 trial of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma who have not received previous systemic anticancer therapy First Phase 2 data from the CaboGIST study (trial 1317) from the European Organization for Research and Treatment of

The Posiflex Group Showcases an Ecosystem of Connected Solution Endpoints with IoT Remote Monitoring at Computex 201924.5.2019 01:00:00 CESTPressemelding

For the Computex 2019 show, The Posiflex Group is featuring leading solution technology from the family of brands as a fully Serviced IoT Ecosystem. Solution end points include: Connected Modular Kiosks, POS Terminals, and Digital Signage solutions from Posiflex and KIOSK Information Systems Smart Medical Displays with gesture controls from Portwell Connected Gaming Solutions with Player Tracking Technology from Portwell subsidiary, Ganlot The booth display is based on common field service endpoints represented in a European Manor Destination Resort setting. Field solutions for an array of vertical market applications include QSR ordering, cinema ticketing, fashion retail customer loyalty, interactive signage, hotel / medical center check-in and bill pay, as well as casino gaming technology. This year, in addition to their renowned POS product suite, Posiflex will be featuring newly introduced Modular Kiosk platforms (co-designed by KIOSK and Posiflex), which are configure-to-order sta

Audi China President Thomas Owsianski to Keynote at CES Asia 201923.5.2019 20:00:00 CESTPressemelding

The Consumer Technology Association (CTA)TM today announced that Thomas Owsianski, president of Audi China, will deliver a keynote address at the upcoming CES Asia 2019. Now in its fifth year, CES Asia will run June 11-13, 2019 at the Shanghai New International Expo Centre (SNIEC) in Shanghai, China. Thomas Owsianski’s keynote is scheduled for 4 PM, Tuesday, June 11, where he will unveil Audi’s vision in transforming mobility from a driving experience to a digital adventure. Mr. Owsianski joined the top management team of Audi China in August 2018 and was named President in October 2018. “Audi has been at the forefront of driving global transformation in the automotive industry through their breakthrough advancements in technology,” said Karen Chupka, executive vice president, CES. “Innovation has revolutionized the transportation experience, and we welcome Mr. Owsianski to the CES Asia stage to share Audi’s vision for the future of global mobility.” Throughout Asia and beyond, technol

ITechLaw Publishes New Book and Opens Global Public Comment Period on Draft Principles for Responsible Artificial Intelligence23.5.2019 19:11:00 CESTPressemelding

The International Technology Law Association (ITechLaw) has published Responsible AI: A Global Policy Framework, a new book that provides an in-depth review and eight discussion principles that address some of the hottest technology and moral issues of responsible development, deployment and use of artificial intelligence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190523005752/en/ ITechLaw releases new book, Responsible AI: A Global Policy Framework, and opens public comment period. (Photo: Business Wire) Written by a multi-disciplinary group of 54 technology law experts, industry representatives and researchers from 16 countries, the book offers an actionable framework built on the following principles: Ethical Purpose and Societal Benefit, Accountability, Transparency and Explainability, Fairness and Non-discrimination, Safety and Reliability, Open Data and Fair Competition, Privacy, and AI and Intellectual Property.